BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3458709)

  • 1. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells.
    Sugiura M; Shafman T; Kufe D
    Cancer Res; 1984 Apr; 44(4):1440-4. PubMed ID: 6423275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
    Watanabe T; Shafman T; Kufe DW
    J Cell Physiol; 1985 Mar; 122(3):435-40. PubMed ID: 3918047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamine requirements for induction of HL-60 promyelocyte differentiation by leukocyte-conditioned medium and phorbol ester.
    Kufe DW; Griffin J; Mitchell T; Shafman T
    Cancer Res; 1984 Oct; 44(10):4281-4. PubMed ID: 6432308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells.
    Meilhoc E; Moutin MJ; Romani BH; Osborne HB
    Exp Cell Res; 1986 Jan; 162(1):142-50. PubMed ID: 3079592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.
    Gazitt Y; Friend C
    Cancer Res; 1980 May; 40(5):1727-32. PubMed ID: 6154532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
    Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
    Porter CW; McManis J; Casero RA; Bergeron RJ
    Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine.
    Sherman ML; Shafman TD; Spriggs DR; Kufe DW
    Cancer Res; 1985 Nov; 45(11 Pt 2):5830-4. PubMed ID: 3863710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR; Singh LP; Wahba AJ
    Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core.
    Gazitt Y
    Cancer Res; 1981 Jul; 41(7):2959-61. PubMed ID: 6941849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
    Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
    J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F; Strobl LJ; Eick D
    Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.